- Home
- WLDS vs SONN Comparison
WLDS vs SONN Comparison
Compare WLDS & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- SONN
- Stock Information
- Founded
- WLDS 2014
- SONN N/A
- Country
- WLDS Israel
- SONN United States
- Employees
- WLDS N/A
- SONN N/A
- Industry
- WLDS Computer Communications Equipment
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- SONN Health Care
- Exchange
- WLDS Nasdaq
- SONN Nasdaq
- Market Cap
- WLDS 3.4M
- SONN 3.8M
- IPO Year
- WLDS 2022
- SONN N/A
- Fundamental
- Price
- WLDS $1.55
- SONN $9.64
- Analyst Decision
- WLDS
- SONN Strong Buy
- Analyst Count
- WLDS 0
- SONN 1
- Target Price
- WLDS N/A
- SONN $20.00
- AVG Volume (30 Days)
- WLDS 444.2K
- SONN 10.8M
- Earning Date
- WLDS 01-01-0001
- SONN 08-13-2025
- Dividend Yield
- WLDS N/A
- SONN N/A
- EPS Growth
- WLDS N/A
- SONN N/A
- EPS
- WLDS N/A
- SONN N/A
- Revenue
- WLDS $522,000.00
- SONN $1,000,000.00
- Revenue This Year
- WLDS N/A
- SONN $5,376.22
- Revenue Next Year
- WLDS N/A
- SONN N/A
- P/E Ratio
- WLDS N/A
- SONN N/A
- Revenue Growth
- WLDS 536.59
- SONN 978.39
- 52 Week Low
- WLDS $1.20
- SONN $1.08
- 52 Week High
- WLDS $45.32
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- WLDS 51.30
- SONN 92.98
- Support Level
- WLDS $1.46
- SONN $4.19
- Resistance Level
- WLDS $1.62
- SONN $6.00
- Average True Range (ATR)
- WLDS 0.15
- SONN 1.53
- MACD
- WLDS 0.01
- SONN 0.64
- Stochastic Oscillator
- WLDS 25.00
- SONN 47.71
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.